Page last updated: 2024-09-03

methylthio-adp and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

methylthio-adp has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 2 studies

Compound Research Comparison

Studies (methylthio-adp)	Trials (methylthio-adp)	Recent Studies (post-2010) (methylthio-adp)	Studies (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)	Trials (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)	Recent Studies (post-2010) (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
146	2	43	1,541	16	580

Protein Interaction Comparison

Protein	Taxonomy	methylthio-adp (IC50)	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (IC50)
Prostaglandin G/H synthase 1	Homo sapiens (human)		0.13
Prostaglandin G/H synthase 2	Homo sapiens (human)		0.15

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azran, S; Danino, O; Fischer, B; Förster, D; Nadel, Y; Reiser, G	1
Azran, S; Danino, O; Dixit, M; Fischer, B; Förster, D; Kenigsberg, S; Major, DT; Reiser, G; Singh, V	1

Other Studies

2 other study(ies) available for methylthio-adp and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

Article	Year
Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists. Journal of medicinal chemistry, 2013, Jun-27, Volume: 56, Issue:12 Topics: Animals; Antioxidants; Biocompatible Materials; Drug Design; Drug Stability; Humans; Hydrolysis; Models, Molecular; Neuroprotective Agents; Nucleotides; PC12 Cells; Protein Conformation; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y	2013
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action. Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21 Topics: Animals; Antioxidants; Cells, Cultured; Drug Discovery; Humans; Hydrogen Peroxide; Hydrolysis; Iron; Models, Molecular; Neurons; Neuroprotective Agents; Nucleosides; Nucleotides; PC12 Cells; Phosphorothioate Oligonucleotides; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y1	2015

Article

Year

Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.

Journal of medicinal chemistry, 2013, Jun-27, Volume: 56, Issue:12

Topics: Animals; Antioxidants; Biocompatible Materials; Drug Design; Drug Stability; Humans; Hydrolysis; Models, Molecular; Neuroprotective Agents; Nucleotides; PC12 Cells; Protein Conformation; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y

2013

Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.

Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21

Topics: Animals; Antioxidants; Cells, Cultured; Drug Discovery; Humans; Hydrogen Peroxide; Hydrolysis; Iron; Models, Molecular; Neurons; Neuroprotective Agents; Nucleosides; Nucleotides; PC12 Cells; Phosphorothioate Oligonucleotides; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y1

2015